No connection

Search Results

Regulation Score 68 Bullish

US Executive Order Accelerates Psychedelic Research for PTSD Treatment

Apr 20, 2026 09:03 UTC
CMPS, ATAI
Short term

President Trump has signed an executive order to fast-track research and expand access to psychedelic substances for PTSD. The move triggered a sharp rally in specialized biotech stocks, led by Compass Pathways.

  • President Trump signed an executive order for PTSD research
  • Focus on accelerating research and expanding access to psychedelic substances
  • Compass Pathways (CMPS) shares jumped 25% in premarket trading
  • Atai also saw gains following the announcement
  • Market anticipates reduced regulatory friction for psychedelic therapies

Shares of psychedelic-focused biotechnology companies surged in premarket trading following a new executive order from President Donald Trump. The directive specifically targets the acceleration of research and the expansion of access to substances used internationally for the treatment of post-traumatic stress disorder (PTSD). The order signals a potential shift in federal approach toward psychedelic medicine, which may lower regulatory hurdles for companies developing therapies based on these substances. This regulatory tailwind is viewed by investors as a catalyst for clinical trials and the eventual commercialization of PTSD treatments. Market reaction was immediate and pronounced. Compass Pathways (CMPS) saw its shares climb by 25%, while Atai also recorded significant gains as investors priced in the potential for faster regulatory pathways and broader patient access. While the order focuses on research, the market is interpreting this as a broader signal of deregulation within the psychiatric pharmaceutical space. Traders are now monitoring for further guidance on how these substances will be scheduled or fast-tracked through the FDA pipeline.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile